If a baby loses more than 10% of its birth weight, it is necessary to refer the mother and baby to a midwife for assistance in increasing the baby’s weight.

Breastfeeding Problems and Their Management

Breastfeeding is a natural process, but it can come with its own set of challenges. Some of the minor problems that breastfeeding mothers may encounter include frequent feeding, nipple pain, blocked ducts, and nipple candidiasis. These issues can be managed by seeking advice on proper positioning, trying breast massage, and using appropriate medication.

Mastitis is a more serious problem that affects around 1 in 10 breastfeeding women. It is characterized by symptoms such as fever, nipple fissure, and persistent pain. Treatment involves the use of antibiotics, such as flucloxacillin, for 10-14 days. Breastfeeding or expressing milk should continue during treatment to prevent complications such as breast abscess.

Breast engorgement is another common problem that causes breast pain in breastfeeding women. It occurs in the first few days after birth and affects both breasts. Hand expression of milk can help relieve the discomfort of engorgement. Raynaud’s disease of the nipple is a less common problem that causes nipple pain and blanching. Treatment involves minimizing exposure to cold, using heat packs, and avoiding caffeine and smoking.

If a breastfed baby loses more than 10% of their birth weight in the first week of life, it may be a sign of poor weight gain. This should prompt consideration of the above breastfeeding problems and an expert review of feeding. Monitoring of weight should continue until weight gain is satisfactory.

Management of Basal Cell Carcinoma: Referral and Treatment Options

Basal cell carcinomas (BCCs) are slow-growing skin cancers that require prompt referral to a dermatologist for assessment and management. While not urgent, referral should be routine to ensure timely treatment and prevent further growth and potential complications. Treatment options may include surgical excision, curettage and cautery, radiotherapy, or cryotherapy, depending on the size and location of the lesion.

5-fluorouracil cream and diclofenac topical gel are not recommended for the treatment of BCCs but may be used for pre-malignant lesions such as solar keratoses. Referral to oncology for radiotherapy may be considered, but dermatology should be consulted first to explore less invasive treatment options.

A watch-and-wait approach is not recommended for suspected BCCs, as delaying referral can lead to more extensive treatments and potential complications. All lesions suspected of malignancy should be referred to a specialist for further assessment and definitive treatment.

Dukes’ Classification for Colon Cancer

Dukes’ classification is a system used to stage colon cancer based on the extent of tumor invasion and spread. Dukes’ A refers to tumors that are confined to the bowel wall, while Dukes’ B tumors have spread to the serosa. Dukes’ C1 tumors have spread to local nodes, but apical nodes are spared. On the other hand, Dukes’ C2 tumors involve the apical nodes, and Dukes’ D tumors have distant metastases, which carry the worst prognosis.

It is important to understand Dukes’ classification as it helps in determining the appropriate treatment plan for patients with colon cancer. The stage of the cancer is a crucial factor in deciding the best course of action, including surgery, chemotherapy, and radiation therapy. By accurately staging the cancer, doctors can provide patients with the most effective treatment options and improve their chances of survival.

Polymyalgia rheumatica is not associated with an increase in creatine kinase levels. Instead, blood tests typically reveal signs of inflammation, such as elevated white blood cell count, C-reactive protein, and erythrocyte sedimentation rate. These findings, combined with the patient’s medical history and demographic information, strongly suggest polymyalgia rheumatica as the diagnosis. In contrast, conditions such as polymyositis and dermatomyositis typically involve a significant rise in creatine kinase levels, and dermatomyositis also presents with a distinctive rash. Fibromyalgia does not typically show any signs of inflammation on blood tests. While statin-induced myopathy is a possibility based on the patient’s history, the absence of elevated creatine kinase levels makes this diagnosis less likely.

Polymyalgia Rheumatica: A Condition of Muscle Stiffness in Older People

Polymyalgia rheumatica (PMR) is a common condition that affects older people. It is characterized by muscle stiffness and elevated inflammatory markers. Although it is closely related to temporal arthritis, the underlying cause is not fully understood, and it does not appear to be a vasculitic process. PMR typically affects patients over the age of 60 and has a rapid onset, usually within a month. Patients experience aching and morning stiffness in proximal limb muscles, along with mild polyarthralgia, lethargy, depression, low-grade fever, anorexia, and night sweats.

To diagnose PMR, doctors look for raised inflammatory markers, such as an ESR of over 40 mm/hr. Creatine kinase and EMG are normal. Treatment for PMR involves prednisolone, usually at a dose of 15 mg/od. Patients typically respond dramatically to steroids, and failure to do so should prompt consideration of an alternative diagnosis.

In many instances, arthritis symptoms are identified prior to the onset of psoriasis. Symmetrical polyarthritis is a common manifestation of rheumatoid arthritis.

Psoriatic arthropathy is a type of inflammatory arthritis that is associated with psoriasis. It is classified as one of the seronegative spondyloarthropathies and is known to have a poor correlation with cutaneous psoriasis. In fact, it often precedes the development of skin lesions. This condition affects both males and females equally, with around 10-20% of patients with skin lesions developing an arthropathy.

The presentation of psoriatic arthropathy can vary, with different patterns of joint involvement. The most common type is symmetric polyarthritis, which is very similar to rheumatoid arthritis and affects around 30-40% of cases. Asymmetrical oligoarthritis is another type, which typically affects the hands and feet and accounts for 20-30% of cases. Sacroiliitis, DIP joint disease, and arthritis mutilans (severe deformity of fingers/hand) are other patterns of joint involvement. Other signs of psoriatic arthropathy include psoriatic skin lesions, periarticular disease, enthesitis, tenosynovitis, dactylitis, and nail changes.

To diagnose psoriatic arthropathy, X-rays are often used. These can reveal erosive changes and new bone formation, as well as periostitis and a pencil-in-cup appearance. Management of this condition should be done by a rheumatologist, and treatment is similar to that of rheumatoid arthritis. However, there are some differences, such as the use of monoclonal antibodies like ustekinumab and secukinumab. Mild peripheral arthritis or mild axial disease may be treated with NSAIDs alone, rather than all patients being on disease-modifying therapy as with RA. Overall, psoriatic arthropathy has a better prognosis than RA.

Diagnosing and Managing Complications of ERCP: A Case Study

A patient presents with abdominal pain, hypocalcaemia, and a pleural effusion several hours after undergoing an ERCP. The most likely diagnosis is pancreatitis, a known complication of the procedure. Immediate management includes confirming the diagnosis and severity of pancreatitis, aggressive intravenous fluid resuscitation, oxygen, and adequate analgesia. Severe cases may require transfer to intensive care. Intestinal and biliary perforation are unlikely causes, as they would have presented with immediate post-operative pain. A reaction to contrast would have occurred during the procedure. Another possible complication is ascending cholangitis, which presents with fever, jaundice, and abdominal pain, but is unlikely to cause hypocalcaemia or a pleural effusion. It is important to promptly diagnose and manage complications of ERCP to prevent severe complications and improve patient outcomes.

Women who have recently given birth, whether they are breastfeeding or not, can begin taking the progesterone-only pill at any time. However, for this patient who is only 2 days postpartum, it is recommended to prescribe the progesterone-only pill as it does not contain estrogen and is less likely to affect milk production. Additionally, it does not increase the risk of venous thromboembolism, which is a concern for postpartum women until 21-28 days after giving birth. The combined oral contraceptive pill should be avoided until 21 days postpartum due to the risk of thrombosis and reduced breast milk production. The patient cannot resume her previous contraceptives at this time. While an intrauterine device can be inserted during a caesarean section, it is advisable to wait 4-6 weeks postpartum before having it inserted vaginally. It is incorrect to tell the patient that she cannot use any contraception if she wishes to breastfeed, as the progesterone-only pill has been shown to have minimal effect on milk production in breastfeeding women.

After giving birth, women need to use contraception after 21 days. The progesterone-only pill (POP) can be started at any time postpartum, according to the FSRH. Additional contraception should be used for the first two days after day 21. A small amount of progesterone enters breast milk, but it is not harmful to the infant. On the other hand, the combined oral contraceptive pill (COCP) is absolutely contraindicated (UKMEC 4) if breastfeeding is less than six weeks post-partum. If breastfeeding is between six weeks and six months postpartum, it is a UKMEC 2. The COCP may reduce breast milk production in lactating mothers. It should not be used in the first 21 days due to the increased venous thromboembolism risk post-partum. After day 21, additional contraception should be used for the first seven days. The intrauterine device or intrauterine system can be inserted within 48 hours of childbirth or after four weeks.

The lactational amenorrhoea method (LAM) is 98% effective if the woman is fully breastfeeding (no supplementary feeds), amenorrhoeic, and less than six months post-partum. It is important to note that an inter-pregnancy interval of less than 12 months between childbirth and conceiving again is associated with an increased risk of preterm birth, low birth weight, and small for gestational age babies.

The patient in the scenario is experiencing delusional parasitosis, a psychiatric disorder characterized by a fixed, false belief that one is infested by parasites or ‘bugs’. This delusion can lead to extreme measures to try to eradicate the perceived infestation. Delusional parasitosis is also known as Ekbom syndrome. Capgras delusion, Cotard’s delusion, and formication are not applicable in this case.

Understanding Delusional Parasitosis

Delusional parasitosis is a condition that is not commonly known but can be debilitating for those who suffer from it. It is characterized by a persistent and false belief that one is infested with bugs, parasites, mites, bacteria, or fungus. This delusion can occur on its own or in conjunction with other psychiatric conditions. Despite the delusion, patients may still be able to function normally in other aspects of their lives.

In simpler terms, delusional parasitosis is a rare condition where a person believes they have bugs or other organisms living on or inside their body, even though there is no evidence to support this belief. This can cause significant distress and anxiety for the individual, and they may go to great lengths to try and rid themselves of the perceived infestation. It is important for those who suspect they may be suffering from delusional parasitosis to seek professional help, as treatment can greatly improve their quality of life.

Possible Causes of Fever and Rigors in a Patient with a Biliary Stent

Introduction:
A patient with a biliary stent inserted via endoscopic retrograde cholangiopancreatography (ERCP) presents with fever and rigors. This article discusses the possible causes of these symptoms.

Possible Causes:
1. Ascending Cholangitis: This is the most likely option as the patient’s biliary stent and the ERCP procedure are both well-known risk factors for acute cholangitis. The obstruction caused by the stent can lead to recurrent biliary sepsis, which can be life-threatening and requires prompt treatment with broad-spectrum antibiotics and IV fluids.

2. Lower Respiratory Tract Infection: Sedation and endoscopy increase the risk of pulmonary infection, particularly aspiration. However, the biliary stent itself is the biggest risk factor, and the patient’s symptoms point towards ascending cholangitis.

3. Hepatitis: This is an unlikely cause of fever and rigors as there are no risk factors for common causes of acute hepatitis, and Gram-negative rods are not a common cause of hepatitis.

4. Metastatic Pancreatic Cancer: While this condition can increase the risk of infection due to immunocompromised, it does not fully explain the patient’s presentation as it would not cause frank fever and rigors.

5. Pyelonephritis: This bacterial infection of the kidney can cause pyrexia, rigors, and malaise, with Gram-negative rods, especially E. coli, as common causes. However, the recent biliary stent insertion puts this patient at high risk of ascending cholangitis.

Conclusion:
In conclusion, the most likely cause of fever and rigors in a patient with a biliary stent is ascending cholangitis. However, other possible causes should also be considered and ruled out through appropriate diagnostic tests.

Treatment Options for Non-Haemolytic Febrile Transfusion Reaction

Non-haemolytic febrile transfusion reaction is a common acute reaction to plasma proteins during blood transfusions. If a patient experiences this reaction, the transfusion should be temporarily stopped, and clerical checks should be repeated. The patient should be treated with paracetamol, and observations should be repeated more regularly (every 15 minutes).

If the patient’s temperature is less than 38.5 degrees, and they are asymptomatic with normal observations, the transfusion can be continued with more frequent observations and paracetamol. However, if the patient experiences transfusion-associated circulatory overload, furosemide is a suitable treatment option.

Adrenaline is not needed unless there are signs of anaphylaxis, and antihistamines are only suitable for urticaria during blood transfusions. Therefore, it is essential to identify the specific type of transfusion reaction and provide appropriate treatment accordingly.